Global Anti-Viral Drugs market size is predicted to grow from US$ 127250 million in 2025 to US$ 157610 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031. Get Access Now!

Global Anti-Viral Drugs Market Size and Outlook 2025-31

The global Anti-Viral Drugs market size is predicted to grow from US$ 127250 million in 2025 to US$ 157610 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Anti-Viral Drugs Industry Forecast looks at past sales and reviews total world Anti-Viral Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Viral Drugs sales for 2025 through 2031. With Anti-Viral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Viral Drugs industry. This Insight Report provides a comprehensive analysis of the global Anti-Viral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Viral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Anti-Viral Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Viral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Viral Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Viral Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Nucleotide Polymerase Inhibitor &nbsp;&nbsp;&nbsp; Reverse Transcriptase Inhibitor &nbsp;&nbsp;&nbsp; Protease Inhibitor Segmentation by Application: &nbsp;&nbsp;&nbsp; HIV &nbsp;&nbsp;&nbsp; Hepatitis &nbsp;&nbsp;&nbsp; HSV &nbsp;&nbsp;&nbsp; Influenza This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Bristol-Myers-Squibb &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Merck & Co &nbsp;&nbsp;&nbsp; Aurobindo Pharma &nbsp;&nbsp;&nbsp; Cipla &nbsp;&nbsp;&nbsp; Dr Reddys Key Questions Addressed in this Report What is the 10-year outlook for the global Anti-Viral Drugs market? What factors are driving Anti-Viral Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Anti-Viral Drugs market opportunities vary by end market size? How does Anti-Viral Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Anti-Viral Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Anti-Viral Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Anti-Viral Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Anti-Viral Drugs Segment by Type &nbsp;2.2.1 Nucleotide Polymerase Inhibitor &nbsp;2.2.2 Reverse Transcriptase Inhibitor &nbsp;2.2.3 Protease Inhibitor &nbsp;2.3 Anti-Viral Drugs Sales by Type &nbsp;2.3.1 Global Anti-Viral Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Anti-Viral Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Anti-Viral Drugs Segment by Application &nbsp;2.4.1 HIV &nbsp;2.4.2 Hepatitis &nbsp;2.4.3 HSV &nbsp;2.4.4 Influenza &nbsp;2.5 Anti-Viral Drugs Sales by Application &nbsp;2.5.1 Global Anti-Viral Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Anti-Viral Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Anti-Viral Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Anti-Viral Drugs Breakdown Data by Company &nbsp;3.1.1 Global Anti-Viral Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Anti-Viral Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Anti-Viral Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Anti-Viral Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Anti-Viral Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Anti-Viral Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Anti-Viral Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Anti-Viral Drugs Product Location Distribution &nbsp;3.4.2 Players Anti-Viral Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Anti-Viral Drugs by Geographic Region &nbsp;4.1 World Historic Anti-Viral Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Anti-Viral Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Anti-Viral Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Anti-Viral Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Anti-Viral Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Anti-Viral Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Anti-Viral Drugs Sales Growth &nbsp;4.4 APAC Anti-Viral Drugs Sales Growth &nbsp;4.5 Europe Anti-Viral Drugs Sales Growth &nbsp;4.6 Middle East & Africa Anti-Viral Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Anti-Viral Drugs Sales by Country &nbsp;5.1.1 Americas Anti-Viral Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Anti-Viral Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Anti-Viral Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Anti-Viral Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Anti-Viral Drugs Sales by Region &nbsp;6.1.1 APAC Anti-Viral Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Anti-Viral Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Anti-Viral Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Anti-Viral Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Anti-Viral Drugs by Country &nbsp;7.1.1 Europe Anti-Viral Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Anti-Viral Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Anti-Viral Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Anti-Viral Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Anti-Viral Drugs by Country &nbsp;8.1.1 Middle East & Africa Anti-Viral Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Anti-Viral Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Anti-Viral Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Anti-Viral Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Anti-Viral Drugs &nbsp;10.3 Manufacturing Process Analysis of Anti-Viral Drugs &nbsp;10.4 Industry Chain Structure of Anti-Viral Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Anti-Viral Drugs Distributors &nbsp;11.3 Anti-Viral Drugs Customer 12 World Forecast Review for Anti-Viral Drugs by Geographic Region &nbsp;12.1 Global Anti-Viral Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Anti-Viral Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Anti-Viral Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Anti-Viral Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Anti-Viral Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 F. Hoffmann-La Roche &nbsp;13.1.1 F. Hoffmann-La Roche Company Information &nbsp;13.1.2 F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 F. Hoffmann-La Roche Main Business Overview &nbsp;13.1.5 F. Hoffmann-La Roche Latest Developments &nbsp;13.2 GlaxoSmithKline &nbsp;13.2.1 GlaxoSmithKline Company Information &nbsp;13.2.2 GlaxoSmithKline Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 GlaxoSmithKline Main Business Overview &nbsp;13.2.5 GlaxoSmithKline Latest Developments &nbsp;13.3 Bristol-Myers-Squibb &nbsp;13.3.1 Bristol-Myers-Squibb Company Information &nbsp;13.3.2 Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Bristol-Myers-Squibb Main Business Overview &nbsp;13.3.5 Bristol-Myers-Squibb Latest Developments &nbsp;13.4 AbbVie &nbsp;13.4.1 AbbVie Company Information &nbsp;13.4.2 AbbVie Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.4.3 AbbVie Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 AbbVie Main Business Overview &nbsp;13.4.5 AbbVie Latest Developments &nbsp;13.5 Johnson & Johnson &nbsp;13.5.1 Johnson & Johnson Company Information &nbsp;13.5.2 Johnson & Johnson Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Johnson & Johnson Main Business Overview &nbsp;13.5.5 Johnson & Johnson Latest Developments &nbsp;13.6 Merck & Co &nbsp;13.6.1 Merck & Co Company Information &nbsp;13.6.2 Merck & Co Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Merck & Co Main Business Overview &nbsp;13.6.5 Merck & Co Latest Developments &nbsp;13.7 Aurobindo Pharma &nbsp;13.7.1 Aurobindo Pharma Company Information &nbsp;13.7.2 Aurobindo Pharma Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.7.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Aurobindo Pharma Main Business Overview &nbsp;13.7.5 Aurobindo Pharma Latest Developments &nbsp;13.8 Cipla &nbsp;13.8.1 Cipla Company Information &nbsp;13.8.2 Cipla Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.8.3 Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Cipla Main Business Overview &nbsp;13.8.5 Cipla Latest Developments &nbsp;13.9 Dr Reddy�s &nbsp;13.9.1 Dr Reddy�s Company Information &nbsp;13.9.2 Dr Reddy�s Anti-Viral Drugs Product Portfolios and Specifications &nbsp;13.9.3 Dr Reddy�s Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Dr Reddy�s Main Business Overview &nbsp;13.9.5 Dr Reddy�s Latest Developments 14 Research Findings and Conclusion

Report	Global Anti-Viral Drugs Market Growth 2025-2031
Selected License	Multi ID: LPI23542

Buyer Information

Order Summary